Job overview

We are looking to appoint a Registrar in Clinical Oncology from March 2026 on a 6 month contract. 
  
In order to fulfil the responsibilities of the post the appointee will be required to demonstrate that they have experience in oncological management, and preferably will have MRCP or equivalent. The post may also be attractive to a candidate preparing for FRCR.  
  
The post would be particularly suitable for experienced international oncologists wishing to gain further specialist experience in an international tertiary centre. The post could also be tailored to an experienced medical doctor who having completed Foundation and Core Medical competencies (or equivalent), wish to gain a period of focused experience and training in Clinical Oncology before pursuing ST3 training.  

Main duties of the job

The specialty of Clinical Oncology comprises management of cancer using both radiotherapy and systemic therapy (chemotherapy, hormone therapy and biological agents). It offers a unique opportunity to develop expertise in managing cancer patients and engaging in clinical research and academia. A multidisciplinary team approach and effective communication is integral to the specialty of oncology. Most of an average week is spent in outpatient clinics, prescribing chemotherapy, planning radiotherapy and inpatient care. For further details on the specialty and training please go to the RCR website. We encourage all those who are interested in a career in Clinical Oncology to apply.  

Working for our organisation

The Royal Marsden is a world leader in cancer research, treatment and education. Together with our academic partner, The Institute of Cancer Research (ICR), we are the largest comprehensive cancer centre in Europe and the only National Institute of Health Research (NIHR) Biomedical Research Centre specialising in cancer in the UK.

Our mission is to continue to make a national and international contribution to cancer research and treatment, so that more people are cured and quality of life is improved for those with cancer. The Royal Marsden therefore plays an important role in championing change and improvement in cancer care through research and innovation, education and leading-edge treatment.

We have a reputation for delivering high quality performance. We were ranked joint first in the CQC national inpatient survey  results, above  average  in  national  cancer  patient  experience survey and ranked first amongst teaching hospitals in the UK for our staff survey results.

Predominantly the  Trust’s  workload  is  from  within  the  South  West  and  West  London Cancer Networks  but, as  a  specialist  cancer,  the Trust  has  a high  out-of-area  referral  rate for rare cancers,  recurrent  disease  and  treatment-related  problems  including  international referrals.  The Trust operates a shared care model with St George’s Healthcare NHS Trust for paediatric cancer.